Half-year report · HY
6823.TEDINET S100X28N
Period2025-04-01 → 2025-09-30
Filed2025-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥13.6bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥27.9bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥13.0bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥2.0bn | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥1.8bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥2.0bn | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥4.1bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.8bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥2.0bn | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.7bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.5bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.9bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.2bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.5bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥1.2bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥39.7bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥39.1bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥38.2bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.1bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥7.7bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥32.6bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥31.4bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥30.1bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥7.4bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.0bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥7.2bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.8bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.6bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.9bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.2bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥380m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.7bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥968m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥520m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥749m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥398m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥117.77 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥232.19 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥97.27 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 82.1% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.3% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.8% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 24
| Segment | Item | Period | Value |
|---|---|---|---|
| Environmental Equipmentreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥2.6bn |
| Environmental Equipmentreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥2.6bn |
| Environmental Equipmentreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥87m |
| Medical Equipmentreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥6.1bn |
| Medical Equipmentreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥6.1bn |
| Medical Equipmentreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥593m |
| Particle Countersreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥5.0bn |
| Particle Countersreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥5.0bn |
| Particle Countersreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥13.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥13.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥2.0bn |
| Environmental Equipmentreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥2.4bn |
| Environmental Equipmentreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥2.4bn |
| Environmental Equipmentreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥139m |
| Medical Equipmentreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥6.0bn |
| Medical Equipmentreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥6.0bn |
| Medical Equipmentreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥401m |
| Particle Countersreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥4.6bn |
| Particle Countersreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥4.6bn |
| Particle Countersreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥13.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥13.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥1.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 490
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held | InterimInstant_No2MajorShareholdersMember | 1273000 | |
| Shareholding ratio | InterimInstant_No2MajorShareholdersMember | 0.1033 | |
| Number of shares held | InterimInstant_No3MajorShareholdersMember | 1099000 | |
| Shareholding ratio | InterimInstant_No3MajorShareholdersMember | 0.0892 | |
| Number of shares held | InterimInstant_No4MajorShareholdersMember | 492000 | |
| Shareholding ratio | InterimInstant_No4MajorShareholdersMember | 0.0400 | |
| Number of shares held | InterimInstant_No5MajorShareholdersMember | 210000 | |
| Shareholding ratio | InterimInstant_No5MajorShareholdersMember | 0.0170 | |
| Number of shares held | InterimInstant_No6MajorShareholdersMember | 169000 | |
| Shareholding ratio | InterimInstant_No6MajorShareholdersMember | 0.0138 | |
| Number of shares held | InterimInstant_No7MajorShareholdersMember | 166000 | |
| Shareholding ratio | InterimInstant_No7MajorShareholdersMember | 0.0135 | |
| Number of shares held | InterimInstant_No8MajorShareholdersMember | 151000 | |
| Shareholding ratio | InterimInstant_No8MajorShareholdersMember | 0.0123 | |
| Number of shares held | InterimInstant_No9MajorShareholdersMember | 150000 | |
| Shareholding ratio | InterimInstant_No9MajorShareholdersMember | 0.0122 | |
| Number of shares held | InterimInstant_No10MajorShareholdersMember | 133000 | |
| Shareholding ratio | InterimInstant_No10MajorShareholdersMember | 0.0108 | |
| Number of shares held | InterimInstant | 6977000 | |
| Shareholding ratio | InterimInstant | 0.5659 | |
| Number of shares issued shares voting rights | InterimInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | InterimInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 17300 | |
| Number of shares issued shares voting rights | InterimInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 12319400 | |
| Number of voting rights issued shares voting rights | InterimInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 123194 | |
| Number of shares issued shares voting rights | InterimInstant_OrdinarySharesSharesLessThanOneUnitMember | 11000 | |
| Number of shares issued shares voting rights | InterimInstant | 12347700 | |
| Number of voting rights issued shares voting rights | InterimInstant | 123194 | |
| Number of shares held in own name treasury shares etc | InterimInstant_Row1Member | 17300 | |
| Number of shares held in others names treasury shares etc | InterimInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | InterimInstant_Row1Member | 17300 | |
| Shareholding ratio treasury shares etc | InterimInstant_Row1Member | 0.0014 | |
| Number of shares held in own name treasury shares etc | InterimInstant | 17300 | |
| Number of shares held in others names treasury shares etc | InterimInstant | － | |
| Total number of shares held treasury shares etc | InterimInstant | 17300 | |
| Shareholding ratio treasury shares etc | InterimInstant | 0.0014 | |
| Cash and deposits | Prior1YearInstant | 6014015000 | JPY |
| Cash and deposits | InterimInstant | 7379455000 | JPY |
| Notes and accounts receivable trade | Prior1YearInstant | 5619809000 | JPY |
| Notes and accounts receivable trade | InterimInstant | 5104593000 | JPY |
| Electronically recorded monetary claims operating ca | Prior1YearInstant | 2201004000 | JPY |
| Electronically recorded monetary claims operating ca | InterimInstant | 2109402000 | JPY |
| Inventories | Prior1YearInstant | 8034551000 | JPY |
| Inventories | InterimInstant | 8243022000 | JPY |
| Other ca | Prior1YearInstant | 821522000 | JPY |
| Other ca | InterimInstant | 685606000 | JPY |
| Allowance for doubtful accounts ca | Prior1YearInstant | -7457000 | JPY |
| Allowance for doubtful accounts ca | InterimInstant | -7909000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |